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Although the concept of Ca2+ as a universal messenger is well established, it was 
assumed that the regulatory mechanisms of Ca2+-signaling were divided along the line of 
electric excitability. Recent advances in molecular biology and genomics have, however, 
provided evidence that non-excitable cells such as immunocytes also express a wide and 
diverse pool of ion channels that does not differ as significantly from that of excitable cells 
as originally assumed. Ion channels and transporters are involved in virtually all aspects 
of immune response regulation, from cell differentiation and development to activation, 
and effector functions such as migration, antibody-secretion, phagosomal maturation, or 
vesicular delivery of bactericidal agents. This comprises TRP channel family members, 
voltage- and Ca2+-gated K+- and Na+-channels, as well as unexpectedly, components 
of the Ca 2+V1-subfamily of voltage-gated L-type Ca -channels, originally thought to be 
signature molecules of excitability. This article provides an overview of recent observa-
tions made in the field of CaV1 L-type channel function in the immune context, as well as 
presents results we obtained studying these channels in B-lymphocytes.
Keywords: calcium signaling, lymphocytes, myeloid lineage, CaV ion channels, L-type channels, dt40 B-cells, 
dihydropyridines
introduction
Virtually all biological processes, including immune responses, require at some stage the carefully 
orchestrated elevation of cytoplasmic Ca2+ by various molecular mechanisms, which provide crucial 
cellular signals. When it comes to molecular components of ion flow regulation, it was commonly 
assumed that excitable cells such as neurons or cardiac muscle cells possess a panoply of unique ion 
channels and transporters representing the molecular tools of electrical excitability. In contrast, non-
excitable cells such as immunocytes were thought to mainly, if not even in some cases exclusively, rely 
on store-operated Ca2+-entry (SOCE) to generate Ca2+-signals. This pathway, also called capacitative 
Ca2+-entry (1), is triggered by the activation of cell surface receptors and subsequent activation 
of phospholipases that generate the soluble second messenger IP3 (Inositol 3-Phosphate). Through 
binding to IP3-receptors at the surface of the endoplasmic reticulum (ER), IP3 elicits the depletion 
of the ER Ca2+-stores resulting in a first phase of Ca2+-elevation. In response to this store-depletion 
event, Ca2+-permeable channels at the plasma membrane get in turn activated, leading to Ca2+-entry 
from the extracellular space and to a sustained phase of cytosolic Ca2+-elevation and replenishment 
of the stores. In recent years, the molecular identity of the proteins underlying SOCE has been 
unveiled. The STIM proteins were identified as the ER Ca2+-sensors, which in response to ER store 
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depletion interact with, and open the pore of the ORAI ion chan-
nels in the plasma membrane (2–4). Extensive functional studies 
in various populations of immune cells have become available. 
Unexpectedly, genetic deletion of these molecular components of 
store-operated Ca2+-entry has revealed that immune cell develop-
ment and activation is not as reliant on this Ca2+-entry pathway 
as originally hypothesized. For example, although Ca2+-signals 
are known to be generated during development and selection of 
thymocytes, neither humans with genetic deficiencies in ORAI 
and STIM proteins, nor genetically engineered mice lacking 
SOCE show impaired T-cell development and selection (5–7). 
The same is true of B-cell development as no anomalies were 
found in B-cell populations in the bone marrow and secondary 
lymphoid organs of patients with mutations in the Orai1 or Stim1 
genes (6, 7), or in mice with defects in these same molecules or 
STIM2 (5, 8), despite deficient B-cell receptor (BCR)-mediated 
Ca2+-signaling. On the other hand, T-Lymphocyte activation 
is SOCE-dependent, as illustrated by STIM1/ORAI1 deficient 
humans who exhibit lymphoproliferative defects and severe 
combined immunodeficiency (SCID), a phenotype consistent 
with SOCE-deficient mouse models, although murine STIM/
ORAI proteins show a higher level of functional redundancy (9).
Following the crucial characterization of STIM and ORAI 
and the availability of expression datasets in various immune 
cell populations, it has become increasingly clear that beyond 
SOCE, non-excitable immune cells possess a large and diverse 
pool of ion channels involved in all aspects of immune response 
regulation. This includes numerous members of the TRP channel 
family of cationic channels, voltage- and Ca2+-gated K+-channels, 
and also, surprisingly, voltage-gated Sodium channels (10), and 
components of the CaV1 subfamily of L-type voltage-gated Ca2+-
channels (VGCC), originally thought to be signature molecules 
of excitability (11–14).
In excitable cells, voltage-dependent Ca2+-entry has been 
extensively characterized biophysically and pharmacologically. 
These currents were subdivided into several subclasses based 
on these electrophysiological and pharmacological properties 
(15, 16). Molecules mediating “Long-lasting” L-type currents 
are commonly described as high voltage-activated channels with 
comparatively slow activation and rapid deactivation. Another 
important hallmark of L-type channels in the excitable context is 
the strong Ca2+-dependence of their inactivation, and their inhi-
bition by 1,4-dihydropyridines (DHPs). L-type Ca2+-channels are 
often mentioned as signature channels of excitability since they 
couple excitation to contraction in skeletal, cardiac, and smooth 
muscle cells. They are also present in neurons and endocrine cells 
where they participate in a wide range of biological processes 
from cell death to transcriptional regulation or hormone secre-
tion. Although immune cells are not known to undergo massive 
membrane depolarization, and lack the typical voltage-activated 
Ca2+-entry linked to L-type channels in the excitable context, there 
is mounting evidence that pore-forming L-type VGCC α1 subu-
nits, as well as accessory β-subunits, are functionally expressed in 
various types of immunocytes, including B- and T-lymphocytes, 
but also in cells of the myeloid lineage (12–14, 17, 18). L-type 
channel blockers are commonly used to treat cardiovascular 
conditions such as high blood pressure. Understanding the role 
of these channels in the context of immunity and inflammation is 
therefore also relevant therapeutically. Before reviewing the cur-
rent knowledge about the presence and potential involvement of 
L-type channels in the immune system, a brief overview of their 
structure, regulation, and biology will be given.
topology, nomenclature, and regulation 
of Voltage-Gated Ca2+ Channels
The α1 pore-forming subunits of VGCCs are predicted to contain 
a total of 24 transmembrane (TM) spans arranged in four groups 
of six spans where the fourth one functions as a voltage sensor, 
and the loop between the fifth and sixth span is part of the chan-
nel’s ionic selectivity filter (Figure  1). This overall topology is 
common to several other families of cationic channels, such as 
TRP (transient receptor potential), Kv (voltage-gated K+) or CNG 
(cyclic nucleotide-gated) channels, that all harbor the same TM 
architecture. One main difference to VGCCs is, however, that in all 
these other channels the four groups of six TM spans are expressed 
as single independent entities that tetramerize to form a complete 
pore, allowing for the heteromultimerization of several members 
of the same channel family. Although the pore-forming subunit 
of VGCCs is in one continuous polypeptide chain, VGCCs are 
also multi-subunit complexes where the pore-forming α1 subunit 
interacts with regulatory/auxiliary subunits designated β, α2/δ, 
and γ, which are playing an essential role in regulating trafficking 
and assembly, but also in shaping channel activity features such as 
kinetics of activation or inactivation. Ten distinct genes subdivided 
into three phylogenetic subfamilies have been found to encode α1 
subunits in mammals. In an effort to reorganize the nomenclature, 
VGCCs have been renamed CaV (for voltage-gated Ca2+), followed 
by the subfamily number (1–3), and the particular member num-
ber. L-type currents are mediated by four different α1 subunits, 
now called CaV1.1 to 1.4 (formerly α1S, α1C, α1D, and α1F, gene 
names are cacna1s, cacna1c, cacna1d, and cacna1f, respectively) 
(19). Multiple splice variants from all subunits listed above further 
contribute to the amazing molecular plasticity of these channels 
[reviewed in Ref. (16, 20)]. It was, for example, described that for the 
gene encoding human CaV1.2, at least 20 from the 50 exons can be 
subjected to splicing (16). In T-lymphocytes, two splice variants of 
CaV1.4 (α1F) have been found, one lacking major parts of the fourth 
group of TM spans (IVS3–S6), including the voltage sensor and the 
pore loop, and another variant lacking part of the extracellular loop 
connecting IVS3 with S4 (21) (Figure 1). As a result of the deletion 
of exon 37, both these T-cell-specific splice variants exhibit a novel 
and shorter C-terminal end that surprisingly shows significant 
homology to CaV1.1. As might have been expected because of the 
lack of typical voltage-gated Ca2+-entry, it therefore appears that 
T-cell-specific versions of CaV1 channels exist, although they have 
not yet been functionally characterized. A similar CaV1.3 variant 
had been described several years prior in a rat hepatoma cell line, 
and was also assumed to be voltage-insensitive, and thus gated via 
different mechanisms than in excitable cells (22). In addition to the 
extensive mRNA splicing, multiple reports have documented the 
proteolytic cleavage of the C-terminal portions of CaV1.2 (α1C) 
and CaV1.3 (α1D), resulting in truncated channels with altered 
biophysical properties (23–25). Recent studies have shown that 
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the CaV1.2 C-terminal fragment translocates in a Ca2+-dependent 
manner into the nucleus, where it acts as a positive and negative 
regulator of transcription (26, 27). This finding further emphasizes 
the complex and multilayered physiological functions of these 
molecules. Importantly, the predicted topology shown in Figure 1 
results in both protein termini being cytoplasmic, provided the 
channel is inserted into the plasma membrane. The gating of these 
channels is regulated at multiple levels, and often involves the 
interaction of their cytoplasmic regions with gating agents, as well 
as with other modulatory proteins that adjust the extent and kinet-
ics of channel activation to cellular needs. Several molecules can 
bind to the same region of a given channel, like calmodulin (CaM), 
CaBP1, and CaMKII, which all interact with the N-terminal tail 
of CaV1.2, potentially resulting in a competition between these 
proteins to regulate channel kinetics (28). One extensively studied 
example is the modulation of voltage-gated Ca2+ channels by the 
Ca2+-sensor CaM [reviewed in Ref. (29)].
store-operated vs. L-type  
Channel-Mediated Ca2+-entry: 
Unexpected reciprocity
An unforeseen consequence of identifying the molecular compo-
nents of store-operated Ca2+-entry – the ER Ca2+ sensor proteins 
STIM1/2, and the STIM-activated Orai (also CRACM1) plasma 
membrane channels – has been the realization that VGCCs are 
FiGUre 1 | schematic representation of the overall predicted topology 
and of the pore forming CaVα1 subunits: the 24 transmembrane (tM) 
regions of a typical CaV1 pore-forming unit are depicted in a linear 
fashion. In red are the C-terminal protein segments that were found to be 
affected by alternative splicing in T-cells, and might as a result be partly lacking 
in these cells. On the right, one channel is represented as a “half-pore” cross 
section through the plasma membrane. CaVα1 subunits are assumed to show 
the same fold as other cationic channel families, which is characterized by the 
formation of a pore through four groups (I–IV) of six TM domains that line the 
ionic selectivity filter. The voltage-gated sensor that is essential for gating in 
excitable cells is located on TM4 of each group. L-type channels are currently 
discussed as “store-inhibited channels,” representing a novel mechanism of 
Ca2+-signal coordination – upon depletion of the ER Ca2+-stores, the ER 
Ca2+-sensing STIM proteins activate store-operated Orai-channels, but at the 
same time, repress L-type channels. The mode of activation of L-type channel 
family members in various immune cell types remains to be determined.
“store-inhibited” channels (30). As several studies have docu-
mented, there appears to be a reciprocal relationship between 
store-operated and VGCC-mediated Ca2+-entry pathways ensur-
ing a coordinated activation pattern of these two major Ca2+-
signaling pathways. Two simultaneous reports in 2010 described 
how the ER Ca2+-sensor STIM1 not only activates Orai-channels, 
but also suppresses the activation of CaV1.2 (31, 32). As a similar 
relationship was recently discovered between STIM1 and T-type 
Ca2+-channels (33), this reciprocity might represent a common 
mode of Ca2+-signal coordination. Moreover, beyond IP3 recep-
tors, STIM proteins have also been shown to colocalize with the 
intracellular Ca2+ release ryanodine receptors (RyR) in T-cells, 
indicating the functional coupling of RyR and SOCE (34). A 
tight relationship also exists between the SOCE machinery and 
the SERCA pumps that are responsible for refilling the ER stores 
(35). Thus, STIM is emerging as a molecular hub for cellular Ca2+ 
homeostasis regulation. This could have important implications 
when considering the physiological and potentially pathological 
consequences of STIM function alterations.
evidence for L-type Channels in the 
immune Context
The presence of L-type channels in immune cells is mostly 
discussed in lymphocytes, but several studies also describe their 
occurrence in cells of the myleoid lineage. As mentioned before, 
July 2015 | Volume 6 | Article 3754
Davenport et al. CaV1 L-type channels in immune cells
Frontiers in Immunology | www.frontiersin.org
the DHP sensitivity of L-type channels has been extensively used 
to assess the role of these channels under various circumstances 
and in diverse cell types. Since these drugs have been applied 
therapeutically already for decades and are “valuable and widely 
used agents in the management of essential hypertension and 
angina” (36), researchers early on have investigated the pos-
sible effect of these therapeutics on lymphocytes, and found 
that Ca2+-flux and cell proliferation in response to activation are 
diminished in lymphocytes exposed to these compounds. The 
potential immunosuppressive action of DHPs, in particular at 
the comparatively low concentrations used clinically, remains 
however uncertain. A possible synergy between DHPs and 
cyclosporine A, a combination frequently used in transplantation 
patients, has been described (37).
An important clue to the potential role of L-type channels 
in immunity comes from patients with rare genetic diseases 
affecting CaV1 ion channels, and who also suffer from immune 
impairments. Because cardiac issues are usually severe and 
lead to the most acute and life-threatening health crises in 
these children, the known immune defects they present have 
only been characterized superficially. Timothy syndrome (TS) 
is a complex disorder caused by point mutations in the CaV1.2 
gene. The mutated channels were found to generate sustained 
inward Ca2+-currents originating from an almost complete loss 
of voltage-dependent channel inactivation (38). Severe infec-
tions, particularly bronchial and sinus infections, show a higher 
incidence and severity in individuals with TS, suggesting a sig-
nificant role for CaV1.2 in mounting a potent immune response 
in humans (39). In the following, an overview of the current 
knowledge about L-type channel function in major immune cell 
types will be given.
L-type Channels in t-Lymphocytes
Most of our knowledge about the involvement of CaV channels in 
the immune context was acquired in T-lymphocytes. As several 
excellent contributions in a recent special issue of Frontiers 
Immunology entitled “The Regulation of Calcium Homeostasis 
in T Lymphocytes” have provided in-depth reports about L-type 
channels in T-lymphocytes (13, 14, 40), we will only give a suc-
cinct review of this topic.
Although earlier reports had suggested the presence of mem-
bers of the L-type family of ion channels in T-cells (22), it is mostly 
over the past decade that this unexpected finding has been more 
closely investigated. The group from Wilfred Jefferies published 
the first detailed evidence of CaV involvement in human T-cells by 
showing expression of cacna1f (CaV1.4) in Jurkat T-cells in addi-
tion to primary peripheral blood CD4 and CD8 T-cells (11). The 
function of cacna1f expression was confirmed through a series of 
experiments utilizing L-type-specific DHP agonist and antagonist. 
These studies revealed that pharmacological manipulation of CaV 
channels in T-cells modulated T-cell receptor (TCR)-dependent 
Ca2+ flux, influenced phosphorylation and translocation of key 
TCR signaling pathways, regulated production of the proinflam-
matory cytokine IL-2 and upregulation of the IL-2R (CD25), and 
blunted TCR-induced proliferation. It has since been shown that 
both CD4+ and CD8+ T-cells express unique patterns of L-type 
CaV channels, dependent upon their lineage differentiation and 
activation status (13).
Useful insights have been gained from studies conducted in 
mouse models with alterations in genes encoding CaV-channel 
subunits (41–43). Mice deficient in the cytoplasmic β-subunits 
β3 (knock-out), or β4 (spontaneous mutation), show normal 
intrinsic T-cell development – previously described anomalies 
in thymus development in the β4 mutant (44) are likely due 
to the onset of neuropathy exhibited in these mice at 2 weeks 
of age (41). It was further concluded through bone marrow 
chimera experiments that the β4 mutant contained a normal 
assortment of peripheral CD4 and CD8 T-cells, and a preserved 
naïve T-cell phenotype (CD44loCD62Lhi, CD25−CD69−). In con-
trast, β3-deficiency resulted in a dramatic reduction of splenic 
CD8+ T-cells, of which a significant portion presented with 
an activated phenotype (CD44hiCD62Llo) (42). TCR-mediated 
Ca2+ responses in CD4+ T-cells are diminished in both CaVβ3- 
and CaVβ4-deficient mice, directly contributing to impaired 
nuclear translocation of the Ca2+-sensitive transcription factor 
NFAT, leading to reduced production of the proinflammatory 
cytokines IFNγ and IL-4 (41, 42). Although CD4+ and CD8+ 
T-cells express unique profiles of β subunits (β4/β3 and β2/β3, 
respectively), it has yet to be clarified how these patterns directly 
regulate T-cell biology. Auxiliary subunits of CaV channels come 
in many different variants, increasing the molecular diversity of 
these channels. Functionally, auxiliary subunits enhance mem-
brane expression of the channels, influence current properties, 
and shape the composition of signaling complexes associated 
with the channels. As subunit interactions of L-type channels 
are highly promiscuous, cell-specific expression patterns are 
crucial to define the type of channel complex being functionally 
expressed (45). Thus, it is plausible that the unique character-
istics of each β subunit (subcellular localization coordination, 
phosphorylation status, complex formation with other adaptor/
signaling molecules) could be an additional layer of T-cell 
regulation (42, 45).
Interestingly, CD8+ T-cells show a state-dependent expression 
pattern for CaV1 channels. Although the CD8+ T-cell population 
as a whole expresses mRNA transcripts for all four members of 
the CaV1 family, CaV1.1 and CaV1.4 exhibit differential regulation. 
Whereas CaV1.4 protein is found in naïve but not in activated CD8+ 
T-cells, CaV1.1 expression is the opposite during TCR stimulation, 
showing prominent expression in activated CD8+ T-cells, but not 
naïve. In addition, only the β3 regulatory subunit was shown to be 
prominently expressed in CD8+ T-cells (42). In this same study, 
utilizing β3-deficient mice, it was observed that peripheral naïve 
CD8+ T-cell homeostasis was dramatically altered. In the absence 
of β3, although thymic T-cell development was not perturbed, 
peripheral CD8+ T-cell numbers were greatly diminished. It was 
shown that CD8+ T-cells in β3−/− mice exhibit a skewed activated 
phenotype (CD44hiCD62Llo) in the absence of any simulation/
immunization, as well as increased activation-induced cell death, 
and impaired TCR-induced Ca2+ flux, proliferation, and effector 
cell function (as evident by lack of proinflammatory IFNγ, TNFα, 
IL-2 and granzyme B production).
The CD8+ T-cell phenotype and functional capacity in β3−/− 
mice is partly reminiscent of exhausted T-cells in chronic viral 
July 2015 | Volume 6 | Article 3755
Davenport et al. CaV1 L-type channels in immune cells
Frontiers in Immunology | www.frontiersin.org
infection as shown by the activated phenotype, impaired prolif-
erative capacity and diminished cytokine production, although 
the cardinal marker for exhaustion PD-1 is not upregulated in 
β3−/− CD8+ T-cells (42, 43, 46). In depth analysis of the molecular 
signatures of exhausted antiviral CD8+ T-cells revealed, among 
other things, an absence in NFAT nuclear translocation (46, 47). 
In addition to the absence of nuclear NFAT in exhausted CD8+ 
T-cells, alteration in the balance of NFAT and its binding partner 
AP-1 has dramatic effects on the targeted transcriptional program 
(48). When NFAT fails to complex with AP-1, the genes targeted 
are associated with anergy, tolerance, and exhaustion (48–50). 
Although the phenotypic and functional discrepancies observed 
in CD8+ T-cells in β3−/− mice do not completely mirror those of 
exhausted antiviral CD8+ T-cells, it is convincing to predict that 
the culmination of TCR-mediated Ca2+ flux and coordinated 
regulation of NFAT nuclear translocation mediated by the CaV1 
β3 subunit has the potential to regulate the onset of CD8+ T-cell 
exhaustion.
It was also shown that the absence of β3 regulatory subunit 
resulted in a complete loss of cellular CaV1.4 protein. The 
authors concluded from their observations that the CaV1.4-β3 
complex in naïve CD8+ T-cells contributes to antigen inde-
pendent, MHC-triggered Ca2+ responses that are required for 
tonic signaling and the survival of these cells. This finding was 
confirmed and further expanded when the phenotype of mice 
constitutively lacking CaV1.4 was characterized. Recapitulating 
previous investigations, these studies demonstrated that CaV1.4 
(cacna1f) is needed for the survival of peripheral naïve CD4 
and CD8 T-cells. They further showed that CaV1.4 deficiency 
significantly reduced both CD4+ and CD8+ antigen-specific 
T effector cell responses. When challenged with ovalbumin-
expressing Listeria, cacna1f−/− mice exhibited a significantly 
reduced expansion in antigen-specific CD4+ and CD8+ T 
effector cells, in addition to impaired CD8+ T-cell-mediated 
cytotoxicity (43).
Expression analyses of CaV1 pore-forming subunits in differ-
ent subsets of CD4+ Th cells have shown that CaV1.2 and 1.3 are 
a hallmark of Th2 cells where they promote cytokine production 
(51, 52). Administration by airway inhalation of a combination of 
CaV1.2 and CaV1.3 antisense oligonucleotides provided protection 
against the development of Th2-dependent airway inflammation 
and hyperreactivity in mice (53), pointing at the therapeutic 
potential of airway-targeted inhibition of CaV-channels for the 
treatment of asthma. In humans, gene expression analyses in 
circulating blood cells revealed expression of CaV1.2, 1.3, and 
1.4, as well as of accessory subunits required to form functional 
CaV channels (54). Comparably to mice, CaV1.4 was detected in 
Th1 and Th17 cells, whereas CaV1.2 is selectively expressed in 
Th2 cells. Although CaV1.4 was down-regulated following TCR-
stimulation of Th1 cells, this was not the case for CaV1.2 in Th2 
cells. Accordingly, pharmacological inhibition of TCR-mediated 
cytokine production was specifically reduced in Th2, but not in 
Th1, cells (54).
The differential expression profile of expressed CaV subunits 
in T lymphocytes is therefore expected to be an important fac-
tor in generating the diversity of Ca2+ signals required for T-cell 
development, homeostasis, and effector functions.
L-type Channels in B-Lymphocytes
The generation of Ca2+-signals in B-lymphocytes appears to be 
diversified and not as dependent upon STIM/Orai-mediated 
store-operated Ca2+-entry as originally anticipated (55). In mice 
lacking both ER Ca2+-sensor proteins Stim1 and 2 selectively 
in B-cells (Mb1-Cre-mediated deletion), B-cell development 
was normal, although SOCE was shown to be largely deficient. 
Antibody production, as well as LPS- and anti CD40-dependent 
B-cell proliferation, are also intact in these mice. However, BCR-
mediated proliferation is strongly diminished, and B-cell-derived 
production of the anti-inflammatory cytokine IL-10 is severely 
reduced as a result of defective activation of the Ca2+-regulated 
transcription factor NFAT, leading to enhanced Th1-driven 
experimental autoimmune encephalomyelitis (EAE) (8).
Because many Ca2+-regulated B-cell functions remain intact 
in the absence of functional SOCE, it suggests that other Ca2+-
signaling mechanisms must exist in these cells. Comparatively lit-
tle is known about the role of L-type channels in B-lymphocytes. 
Several pharmacological studies have demonstrated that block-
ing L-type channels in human B-cells reduces BCR-induced 
Ca2+-entry (17, 56). In freshly isolated rat B-cells, an antibody 
against CaV1.3 was found to block IgD-mediated Ca2+-responses 
(56). In this same study, it was confirmed that depolarization 
does not result in a Ca2+-response in B-lymphocytes, however, 
a cGMP-dependent protein kinase involvement was discovered. 
In the human L3055 B-cell line, gene and protein expression of 
CaV1.2α1 and β1 was demonstrated, whereby the CaV1.2α1 ver-
sion expressed in these cells appeared to be non-voltage-gated 
and truncated in comparison to the version present in cardiac 
tissues (17). In this same study, an antibody raised against the 
extracellular region of CaV1.2 was found to trigger a Ca2+-flux, 
indicating functional expression of this channel at the plasma 
membrane of L3055 B-cells. A prior report about a CaV1.2α1 
version expressed in murine erythroleukemia cells document 
the occurrence of putatively voltage-insensitive versions of the 
CaV channels expressed in non-excitable cells. This channel can 
be blocked by nifedipine, which partially inhibits differentiation 
of these cells. This CaV1.2 variant lacks the first four segments 
of domain I of the pore-forming subunit, and does not produce 
measurable currents when expressed by itself in Xenopus oocytes 
(57). Therefore, the gating mechanism of this CaV1.2 variant 
remains unknown. A study performed on subsets of sorted splenic 
mouse B-cells mentions that BCR-mediated Ca2+-mobilization 
in transitional T1 B-cells is more sensitive to the L-type channel 
blocker verapamil than that in T2 cells (58). From our review of 
the literature, there is currently no answer to the question under 
which circumstances and in which particular subsets of B-cells 
particular L-type channel subunits are expressed in vivo.
studying L-type Channel Function in  
dt40 B-Cells
Gene and Protein Expression of CaV1  
Subunits in DT40 Cells
To further address the potential role of L-type Ca2+ channels 
in B-lymphocytes, we chose to utilize the chicken DT40 B-cell 
line that allows for the comparatively easy genomic disruption 
FiGUre 2 | Gene and protein expression of CaV1α1 family members in 
dt40 B-cells. (a) RT-PCR using primer combinations specific for the 
indicated chicken version of CaV1.2 (1.5 kb,), 1.3 (1.6 kb), and 1.4 (656 and 
761 bp, lanes 1 and 2, respectively). M = marker. All PCR-fragments have 
been cloned and sequenced for verification. The negative control lanes (Cont) 
are reactions containing RNA as template. (B) Western blot from DT40 
membrane fraction lysates developed using L-type α1 PAN antibody. As a 
positive control, the excitable pancreatic rat beta cell line INS-1 was used.
July 2015 | Volume 6 | Article 3756
Davenport et al. CaV1 L-type channels in immune cells
Frontiers in Immunology | www.frontiersin.org
of genes of interest due to an unusually high rate of homologous 
recombination (59). DT40s have been shown to express an IgM 
isotype BCR at the cell surface, and BCR-stimulation by anti 
IgM leads to PLCγ2 activation and subsequent cytosolic [Ca2+] 
elevation. Signaling components of the avian BCR-pathway show 
very high conservation to their mammalian counterparts, and 
the DT40 system has been extensively used to characterize this 
pathway [reviewed in Ref. (60)].
We first aimed at defining the expression pattern of individual 
pore-forming subunits of the CaV1 L-type family of channels in 
DT40 wild-type cells. After identifying in the NCBI database the 
chicken homologs of the mammalian CaV1.1, 1.2, 1.3, and 1.4, 
we performed RT-PCR experiments. We found all CaV1 genes 
except CaV1.1 to be expressed in DT40 cells (Figure  2A). The 
amplified ~1.5 kb from the 3′ end of CaV1.2 and 1.3 DT40 cDNA 
were cloned and sequenced, and are encoding the complete cyto-
plasmic C-terminal domains of these two channels. In order to 
confirm that also proteins from these channels can be detected in 
DT40s, we conducted simple cell fractionation experiments, and 
used the excitable INS-1 rat pancreatic beta-cell line as a posi-
tive control. To visualize the channels, we used a PAN-antibody 
recognizing an epitope present in all L-type α1 pore-forming 
subunits (aa1506-1524 of rat CaV1.1), which is conserved in 
the chicken version as well. In the DT40 cell membrane frac-
tion, a band of the same size as a strong signal obtained in the 
INS-1 cells (~200 kDa) was detected, indicating that full-length 
α-subunits are expressed in DT40 B-cells (Figure  2B). Lower 
molecular weight bands were also seen, suggesting degradation 
or shorter splice variants. As these results were obtained using a 
PAN anti-CaV1-antibody, we cannot conclude which combina-
tion of the three subunits whose genes are expressed, CaV1.2, 1.3, 
or 1.4, is present at protein level. Because individual antibodies 
against each of the subunits are recognizing epitopes that are not 
well conserved in chicken, this question could not be further 
addressed using existing reagents.
Effect of L-Type Inhibitor on BCR-Mediated Ca2+-
Signals in DT40s
As mentioned previously, several pharmacological studies using 
inhibitors of L-type channels such as nifedipine or diltiazem 
have shown a decrease of the Ca2+-response following receptor 
ligation in lymphocytes. We confirmed this finding in wild-type 
DT40 cells by showing a dose-dependent diltiazem-mediated 
 inhibition of the Ca2+-signal following BCR-stimulation 
(Figure 3A). However, diltiazem had no effect on the pharma-
cological depletion of intracellular ER stores and subsequent 
activation of store-operated Ca2+-entry using the SERCA-pump 
inhibitor thapsigargin, suggesting that diltiazem targets a BCR-
specific event that is not triggered by thapsigargin (Figure 3B). 
The anti-IgM-mediated depletion of the Ca2+-stores in the 
absence of extracellular Ca2+ was not inhibited by diltiazem 
(Figure 3C). Solely the second phase of Ca2+-elevation requiring 
entry from the extracellular space was affected, and the amplitude 
of Ca2+-elevation following exposure to thapsigargin was again 
unchanged by the addition of diltiazem. Noticeably, a similar 
pattern was observed in murine CD4+ T-cells lacking the CaVβ3-
subunit required for proper trafficking of the CaV1 subunits; a 
decrease in the amplitude of the Ca2+-response was only observed 
after cross-linking of the TCR, but not following the application 
of thapsigargin (41). In this context, it is interesting that a recent 
study characterizing CaV1.4-deficient (Cacna1f−/−) mice has 
shown that whereas naïve CD44lo CD4+ T-cells show a CaV1.4 
dependence for both their TCR- and thapsigargin-mediated 
Ca2+-responses, more mature CD44hi CD4+ T-cells exhibit a 
pattern similar to the diltiazem effect in DT40 B-cells with only 
their TCR-mediated, but not their thapsigargin-induced Ca2+-
response relying on CaV1.4 (43). The molecular basis for this 
differential CaV-dependence of  pharmacological store-depletion 
vs. immunoreceptor-mediated Ca2+-signals in certain immune 
cell subsets remains to be elucidated.
Because DHPs need to be applied in the higher μM range 
to elicit an effect on the Ca2+-response of immunocytes, their 
specificity under these conditions has been questioned since an 
inhibitory effect on other channels such as K+ channels (KV and 
KCa) was shown in some studies. However, as discussed by Kotturi 
et al. (11), in these cases the reported effects were not consistent 
with the observations made in immune cells. It is therefore very 
probable that the Ca2+-entry pathway inhibited by diltiazem in 
DT40 cells originates from CaV variants that appear to be less sen-
sitive toward this compound than their counterparts expressed in 
the excitable context.
Inducible Deletion of CaV1.3α1 in DT40 B-Cells
The results of the gene-expression and pharmacological studies 
in DT40s presented above confirmed the presence and potential 
functional relevance of L-type channels in this B-cell line. We 
therefore decided to utilize the high genomic plasticity of DT40 
cells to generate DT40 lines in which genes encoding L-type 
channels are disrupted, beginning with CaV1.3 α1. To this aim, 
we chose a targeting strategy that resulted in the deletion of exons 
encoding several TM regions, in particular S4, S5, and S6 that are 
including the putative pore-forming loop between S5 and S6 (see 
also Figure 1). We opted to delete the exons encoding S4–S6 of 
FiGUre 3 | pharmacological inhibition of BCr-mediated Ca2+-response by the L-type channel blocker diltiazem: dt40 cells were loaded with the 
fluorescent Ca2+-dye Fura-2 and the cells stimulated either through the addition of chicken anti-igM (BCr-ligation) or thapsigargin (pharmacological 
store-depletion) into the cuvette.  (Continued)
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The measurements were performed using a spectrofluorometer (Photon 
Technology International) at 37°C. (a) Dose dependence of the inhibitory effect 
of diltiazem on BCR-mediated cytosolic Ca2+-mobilization. (B) Effect of 
diltiazem on the store-operated Ca2+-response elicited by thapsigargin in DT40 
cells (C) Diltiazem inhibition of the influx of extracellular Ca2+ following 
BCR-ligation. DT40 cells were loaded with the fluorescent Ca2+-dye Fura-2 in 
Ca2+-free buffer, and the cells stimulated through the sequential addition of 
chick anti IgM, 2 mM Ca2+, and thapsigargin into the cuvette.
FiGUre 3 | Continued
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the chicken cacna1d gene within the first six TM group (IS4–S6). 
We designed a “conventional” targeting construct allowing for the 
exchange of the CaV1.3 region of interest against a “recyclable” 
puromycin resistance cassette (flanked by loxP sites, generous 
gift from Dr. Jean-Marie Buerstedde). DT40 cells stably express-
ing a tamoxifen (TX)-inducible version of the Cre recombinase 
[MerCreMer, kindly provided by Dr. Michael Reth (61)] for 
potential inducible Cre-mediated genomic deletions were trans-
fected with the targeting construct depicted in Figure  4A. We 
identified by Southern blot (Figure  4B) multiple DT40 clones 
with targeted integration of the puromycin resistance gene into 
the gene encoding CaV1.3 with an efficiency of over 25% (5 from 
19 analyzed clones). We then tried to target the second allele using 
a different drug resistance cassette (against histidinol), and unex-
pectedly did not obtain any double-targeted DT40 clones, despite 
screening over 50 independent cell clones, a number that in our 
experience is largely sufficient to isolate the desired doubly tar-
geted mutant cells. We thus concluded that the deletion of CaV1.3 
is deleterious to DT40 cells, and designed an alternative targeting 
construct allowing for the inducible deletion of the same IS4–S6 
encoding genomic region using the flox/Cre recombinase system 
(Figure 4A, bottom construct). Using this strategy, we were able 
to obtain TX-inducible deletion of the targeted CaV1.3 genomic 
region. We determined by RT-PCR that following TX-treatment 
and excision of the floxed cacna1d region, the complete CaV1.3 
transcript appears to be missing in these DT40 cells (Figure 4C). 
The analysis of total CaV1 proteins detected with the PAN anti-
body by immunoblotting showed that the high-molecular band 
(>200  kDa), which putatively represents all full-length CaV1 
channels in DT40s, is still present after deletion of CaV1.3. This 
result might have been expected since our gene expression stud-
ies have demonstrated that CaV1.2 and CaV1.4 are also present in 
DT40s (Figure 2A). Noticeably, a smaller (~90 kDa) band seems 
to disappear in CaV1.3−/− DT40 cells (Figure  4D). Although 
we need to confirm this result by cloning the CaV1.3 version(s) 
expressed in DT40 cells in the future, a possible interpretation is 
that CaV1.3 is not (solely) expressed as a full-length ion channel 
in DT40s. This is consistent with findings described above that 
both in B- and T-lymphocytes, L-type variants shorter than their 
excitable counterparts can be identified. The characterization of 
immune variants of L-type channels will be essential to elucidate 
the role of these proteins in this context. As discussed in sec-
tion topology, nomenclature, and regulation of voltage-gated Ca2+ 
channels of this article, immune splice variants are known which 
lack some of the TM spans containing the voltage sensor, consist-
ent with the observation that depolarization does not appear to 
activate Ca2+-signals in immunocytes. It is also conceivable that 
some of the truncated CaV versions might actually not function 
as ion transport pathways, and instead fulfill other cellular roles, 
as illustrated by studies mentioned previously showing the ability 
of C-terminal portions of CaV proteins to translocate into the 
nucleus to act as transcriptional regulators (26, 27).
We found that following deletion of CaV1.3, DT40 cells show a 
marked decrease in growth rate (Figure 5A), which is potentially 
causal to our failure to obtain DT40 clones constitutively deficient 
in CaV1.3 using a conventional targeting strategy. Based on simple 
counts of dead cell bodies, it does not appear that cell death is 
substantially increased in the CaV1.3−/− DT40s, perhaps point-
ing at a defect in cell proliferation, rather than a deregulation of 
apoptotic, necrotic, or cell survival pathways (Figure 5A, dashed 
lines), although this will need to be more carefully investigated 
in the future. We analyzed the effect of the CaV1.3 deletion on the 
Ca2+-response triggered by anti-IgM and thapsigargin treatment, 
and did not observe any change in the extent or shape of the Ca2+-
responses under these conditions, nor did we see a difference in 
the effect of diltiazem on the Ca2+-increase (Figure 5B). Although 
speculative, this result might suggest that CaV1.3′s biological 
effect is not mediated by Ca2+ influx, which might be further 
corroborated by the observation discussed above that a protein 
substantially smaller than full-length CaV1.3 is seeing as missing 
in the CaV1.3−/− cells. Alternatively, it might be that CaV1.3 is not 
activated downstream of BCR ligation, and that we need to test 
other triggers, for example, through GPCRs. We have indications 
that CaV1.2 deletion in DT40s also requires an inducible strategy, 
suggesting that CaV1.2 and CaV1.3 fulfill non-redundant roles in 
DT40s. Ultimately, for a more complete picture of the function of 
these channels in DT40s to be drawn, a full set of CaV1-deficient 
DT40 lines will need to be generated, including cell lines with 
combined deletions of CaV1.2, CaV1.3, and CaV1.4. These cell 
lines will represent a useful set of reagents to assess the respective 
contribution of these different pore-forming CaV subunits in the 
context of BCR-signaling.
L-type Channels in immune Cells of  
the Myeloid Lineage
Insights into the possible involvement of L-type channels in the 
development, homeostasis, or biological function of cells of the 
myleoid lineage are few. It is, however, known that L-type chan-
nel blockers such as diltiazem, which are clinically widely used 
to treat hypertension, also have anti-inflammatory effects (62). 
This could have clinical implications as pointed out in a recent 
study demonstrating the beneficial effect of diltiazem to prevent 
aneurysm formation in a mouse model through the inhibition of 
inflammatory cytokine production by monocytic cells (18).
In neutrophils, pharmacological inhibitors of L-type chan-
nels have been reported to reduce the Ca2+ response of human 
polymorphonuclear neutrophils (PMNs) to a neuropeptide (63), 
and to reduce the release of elastases and the production of ROS 
from these cells via diminished cytosolic Ca2+ mobilization and 
FiGUre 4 | targeting strategy of the CaV1.3 encoding gene cacna1d, 
and validation of the tamoxifen-inducible cacna1d disruption in the 
dt40 cell line: (a) schematic representation of the magnified 
genomic organization of the region containing the exons encoding 
tM spans is4-s6 of the chicken CaV1.3 channel that was deleted is 
shown. The constitutive and inducible targeting constructs are depicted 
underneath. The expected BamHI fragment sizes by Southern are indicated 
by arrows. (B) Representative Southern blot showing one of the CaV1.3± 
clones and of the CaV1.3flox/− clones before (lane 1) and after tamoxifen  
(lane 2)-induced deletion of the cacna1d region of interest in comparison to 
a cacna1d± clone (lane 3). (C) RT-PCR of wild-type DT40 cells and of one 
CaV1.3flox/− clone before and after tamoxifen (TMX)-induced deletion of the 
cacna1d region of interest using cacna1d-specific primers. The unrelated 
chicken nudT9 gene was used as a positive control (Pos) to verify the quality 
of the cDNA. Neg control is RNA only. (d) Western blot of membrane 
fraction lysates of wild-type DT40s and excitable INS-1 rat pancreatic cells in 
comparison to one CaV1.3flox/− clone before and after tamoxifen-induced 
cacna1d deletion.
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PKC activation (64). In monocytes, it was similarly reported that 
nifedipine dampens superoxide production and that in addition it 
directly contributes to reducing PKC activity (65). It has also been 
proposed that the anti-inflammatory effects of L-type channel 
blockers is reinforced by the effects of these drugs on suppress-
ing the participation of plasminogen leading to the inhibition of 
macrophage emigration through tissues (66, 67). In peripheral 
blood-derived human dendritic cells (DCs), an early study found 
FiGUre 5 | phenotypic characterization of the CaV1.3-deficient dt40 
cells: (a) Growth curves of dt40 wild-type cells (light gray) in 
comparison to the CaV1.3−/flox cells before (dark gray) and after deletion 
(black) of the floxed region following tamoxifen treatment. Dashed lines 
represent the corresponding numbers of dead cells as determined by trypan 
blue in the same cultures. Cells were split back every 3 days to 0.5 × 106/ml. 
(B) Ca2+-transients in wt vs. CaV1.3-deficient DT40 cells following BCR-
activation with or without L-type channel blocker diltiazem.
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that apoptotic body engulfment and IL-12 production are inhib-
ited by nifedipine (68). More recently a group proposed a model 
in which similar to the situation in cardiac and skeletal muscles, 
membrane depolarization in immature human DCs results in 
CaV1.2 activation, which in turn triggers intracellular Ca2+ release 
via ryanodine receptor 1 (RyR1), resulting in the rapid delivery 
of MHC class II molecules to the plasma membrane (69). The 
role of RyR1 in DCs is further supported by the finding that mice 
carrying a gain of function mutation in RyR1 exhibit enhanced 
DC function (70).
Collectively, theses results suggest that beyond lymphocytes, 
L-type channels also play a significant role in immune cells of the 
myeloid lineage, which will be important to further shed light on.
Concluding remarks
Calcium signals in non-excitable cells such as immune cells are as 
diverse as the biological processes they regulate. In order to accom-
modate this need, immune cells rely on an equally diverse set of 
ion channels that unexpectedly includes molecules thought to be 
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signature molecules of excitability, such as the L-type channels 
discussed in this article. Many questions remain to be addressed, 
such as the nature of the immune-specific L-type channel variants 
expressed in defined subsets of immunocytes, or the important 
but still elusive mechanism of activation of these immune CaV1 
variants since classic depolarization-mediated activation like in 
excitable cells do not seem to be a major factor in immune cells. 
In this context, it might be relevant that a voltage-gated sodium 
channel was recently reported to be crucial for positive selection 
of CD4+ T-lymphocytes (10), opening up the possibility that dur-
ing specific biological processes, and in some distinct cell types 
that harbor the appropriate molecular equipment, voltage-gating 
of L-type channels might be an option, although this remains 
speculative at this time.
Despite these gaps in knowledge it seems now well established 
and accepted in the field that L-type channels are a force to be 
reckoned with in the context of immunity and inflammation. As 
the activity of these channels can be manipulated for therapeutic 
purposes, and the medical community has ample experience 
with drugs targeting L-type channels in the context of hyperten-
sion and cardiac conditions, there is a very real and promising 
potential to utilize these compounds for immunomodulatory and 
anti-inflammatory purposes in the future.
Materials and Methods
Cell Culture
The DT40 cell lines were cultured in RPMI supplemented with 
Pen/Strep, 10% FBS, and 1% chicken serum (Sigma). DT40 wt 
cells stably expressing the Tet-repressor were transfected with 
the targeting constructs for chicken CaV1.3 described under 
“Generation of a CaV1.3-deficient DT40 B-cell line.”
Generation of a Cre-inducible CaV1.3-deficient 
dt40 B-Cell Line
Chicken cacna1d (CaV1.3) genomic DNA was obtained by screen-
ing NCBI chicken genome. The conventional targeting vectors 
[cacna1d::puromycin (puro)] were constructed by replacing the 
genomic fragment containing exons encoding the structurally 
essential TM regions IS4 to IS6 of the CaV1.3 pore-forming 
subunit with puromycin cassettes. This cassette was flanked by 
2.5 and 1.5 kb of chicken cacna1d genomic sequence on the 5′ 
and 3′ sides, respectively. The predicted DNA sequences of all 
constructs were verified by sequencing. The linearized targeting 
construct, cacna1d:puromycin was introduced into DT40 cells by 
electroporation and the cells were subsequently set under selec-
tion in serial dilutions to ensure the obtention of single clones.
Genomic DNA for Southern blot was isolated from drug-
resistant DT40 cell clones, and digested with BamHI. Restriction 
enzyme sites, probe for Southern blot analysis (solid bar) and 
targeted exons are indicated in Figure  4. BamHI fragments 
detected by the probe are shown for wild-type and mutated 
alleles. The first allele targeting using the cacna1d:puro construct 
resulted in homologous recombination with a frequency of 20%. 
The targeting of the second allele using a different drug resistance 
(histidinol), however, failed. We therefore concluded that con-
stitutional homozygous disruption of both cacna1d alleles is 
deleterious to DT40 cells. We thus designed and generated an 
inducible targeting construct allowing for the Cre-recombinase-
mediated deletion of the floxed cacana1d region of interest 
(Figure 4A). The MerCreMer hybrid protein we used was kindly 
provided by Dr. Michael Reth (Freiburg, Germany), and allows 
for TX-inducible activation of the Cre-recombinase activity. The 
successful integration of the cacna1d:Neo-ind construct was 
verified by Southern blot, as well as the Cre-mediated excision 
of the deleted region following addition of TX to the media 
(Figure 4B).
expression analysis by rt-pCr
RT-PCR was performed with chicken DT40 WT RNA for the 
reverse transcription using a Superscript III kit ssDNA synthesis 
kit from Invitrogen following the manufacturer’s protocol. The 
PCR was performed with the Advantage pcDNA Polymerase Mix 
from Clontech, and the following chicken specific oligonucleo-
tides were used:
 - CaV1.2: ACTTCAGATGGGCCAAAACTCTTCC
   CACCTCTTGGAGGCACAGGAGTGAAGG
 - CaV1.3: TACAGGAATGGCACACAGCATCGC
   CAATGAAGCACGTCCATCTTTTGGC
PCR (125  ng of single-strand DNA per reaction) was per-
formed using standard techniques, a 2-step program for 35 cycles 
of 94°C for 20 s, and 60°C for 45 s. The DNA bands have been 
visualized onto an ethidium bromide stained 1% agarose gel 
with a gel documentation system (Bio-Rad). The fragments were 
cloned and sequenced.
immunoblotting
0.1–5 × 106 DT40 wt or mutant cells were plated, cells lysed and 
proteins of the cell membrane fraction were separated by SDS/
PAGE using 8% polyacrylamide gels, and transferred to a PVDF 
membrane. The membranes were analyzed using L-type α1 PAN 
antibody from Alomone Labs.
Calcium Measurements
Cytosolic [Ca2+] was evaluated in the indicated DT40 cell lines 
using the fluorescent Ca2+-sensitive dye fura-2. 4 × 106 cells were 
loaded with 1 μg/ml Fura-2 (Invitrogen) for 30 min at 25°C in 
Ringer buffer and analyzed using a bulk assay in a spectrofluorom-
eter (Photon Technology International) as previously described 
(71). L-type channel inhibitors were ordered from sigma.
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